Omeros Corporation
OMER
#5806
Rank
NZ$2.31 B
Marketcap
NZ$31.97
Share price
2.35%
Change (1 day)
335.05%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2026 (TTM): -NZ$38.85 Million

According to Omeros Corporation's latest financial reports the company's current earnings are NZ$9.89 Million. In 2025 the company made an earning of -NZ$0.21 Billion, an increase over its 2024 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$38.85 Million-80.72%
2025 -NZ$0.21 Billion-27.03%
2024 -NZ$0.28 Billion9.63%
2023 -NZ$0.26 Billion-9.57%
2022 -NZ$0.28 Billion-30.65%
2021 -NZ$0.41 Billion86.28%
2020 -NZ$0.22 Billion99.45%
2019 -NZ$0.11 Billion-49.91%
2018 -NZ$0.22 Billion190.77%
2017 -NZ$74.21 Million-27.96%
2016 -NZ$0.11 Billion-17.61%
2015 -NZ$0.13 Billion1.88%
2014 -NZ$0.13 Billion87.56%
2013 -NZ$65.43 Million
2011 -NZ$47.92 Million-8.96%
2010 -NZ$52.63 Million45.03%
2009 -NZ$36.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.41 B-107,686.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.51 B-43,960.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-NZ$6.76 Million-83.99%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-NZ$26.08 Million-38.22%๐Ÿ‡บ๐Ÿ‡ธ USA